Company: WHWK
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001628280-25-015269
Chunk: 255

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1
Chunk 255
---
, 2023Level 1Level 2Level 3TotalAssets:Money market funds (1)$61,034 $— $— $61,034 U.S. government treasury bills19,458 — — 19,458 Commercial paper— 8,717 — 8,717 Corporate bonds (2)— 13,447 — 13,447 Government agency— 5,482 — 5,482 Total financial assets$80,492 $27,646 $— $108,138 (1)Included in cash and cash equivalents in the accompanying consolidated balance sheets.(2)Includes investments classified as cash and cash equivalent in the accompanying consolidated balance sheet.As of December 31, 2024 and 2023, all marketable securities had a contractual maturity of less than one year.

4. Short-Term Investments and Cash Equivalents

The following table summarizes the Company's short-term investments (in thousands):  As of and for Year Ended December 31, 2024Maturity          (In Years)Amortized CostUnrealized GainsUnrealized LossesFair ValueMoney market funds$27,485 $— $— $27,485 U.S. government treasury billsLess than 112,553 9 — 12,562 Commercial paperLess than 11,743 1 — 1,744 Corporate bondsLess than 14,256 5 — 4,261 Total$46,037 $15 $— $46,052 

130

As of and for Year Ended December 31, 2023Maturity          (In Years)Amortized CostUnrealized GainsUnrealized LossesFair ValueMoney market funds$61,034 $— $— $61,034 U.S. government treasury billsLess than 119,441 17 — 19,458 Commercial paperLess than 18,712 6 (1)8,717 Corporate bondsLess than 113,438 10 (1)13,447 Government agencyLess than 15,486 — (4)5,482 Total$108,111 $33 $(6)$108,138 

5. Accrued Liabilities

Details of accrued liabilities are presented as follows (in thousands):As of December 31,202420